(Q31437264)

English

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

author name string

Capelli D

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Santini G

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

De Souza C

3

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Poloni A

4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Marino G

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Montanari M

6

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Lucesole M

7

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Brunori M

8

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Massidda D

9

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Offidani M

10

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Leoni P

11

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Olivieri A

12

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

300-307

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Amifostine (Ethyol): dosing, administration and patient management guidelines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

Pharmacokinetics of WR-2721.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02149.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2000.02149.X

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31437264&oldid=1643433585"